Tag: COVID-19

  • When Can We Reduce Masking Requirements?

    Key Points: In today’s Recommendations for Industry, we discuss the question: When can our business reduce or rescind our masking requirements? Read more below. Further decline in global COVID cases as deaths stabilize. COVID-19 cases across the globe declined last week for the second week in a row, with illness levels dropping in every region…

  • As COVID Recedes, New Challenges Arise

    Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new COVID-19 cases have dropped by 42%; although death rates and hospitalizations remain high (CIDRAP). However, around the world, COVID-19 still persists. In fact, in Hong Kong, daily cases have now…

  • COVID Declining; Continuing to Impart Lessons for Infectious Disease Control

    Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID and the lessons it continues to impart for infectious disease (and “next pandemic”) control. Read more below. The future of the pandemic is looking clearer as we learn more about infection (NPR). New studies are providing an optimistic picture about immunity…

  • COVID Transitional Period Increases Masking Debate

    Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus in Your Backyard?. A study of white-tailed deer killed by hunters or car crashes found more than 60 percent to be infected with COVID-19, showing that deer could become a…

  • TAG COVID Matrix Showing Encouraging Trends

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s matrix and the current trends of COVID and its variants. Read more below. As countries have begun accepting the endemicity of COVID-19 in society and many countries are loosening pandemic protocols, the WHO warns that it is not the time to completely let go of…

  • Cliché but True: Keep Calm and Carry On

    Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of the day. Read more below. Happy Lunar New Year to all our readers! The U.S. FDA has given full approval to Moderna’s COVID-19 vaccine, henceforth known as Spikevax (VOA News,…

  • TAG Holds Guarded Optimism for the Ebbing of Omicron

    Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine Rule. On Tuesday, OSHA announced its withdrawal of the November 5, 2021, ETS issued to “protect unvaccinated employees of large employers (100 or more employees) from the risk of contracting…

  • What Does an Endemic COVID Really Mean?

    Key Points: In today’s Recommendations for Industry, we discuss the ebbing of Omicron and what a shift to an endemic COVID would really mean. Read more below. The FDA is limiting the use of the following two monoclonal antibodies – (a) bamlanivimad and etesevimab and (b) REGEN-COV – to treat COVID-19 as they are “highly…

  • COVID Case Rates Following Predictable Pattern

    Key Points: In today’s Recommendations for Industry, we discuss Omicron’s path across the US. Read more below. U.S. hospitals have been inundated with Omicron cases; yet, as the vaccine mandate for healthcare workers becomes effective March 15, there is increasing fear that hospital systems may lose some workers.  Additionally, despite signs that Omicron causes milder…

  • Build Your Systems for COVID’s Next Wave

    Key Points: In today’s Recommendations for Industry, we discuss the business management of COVID’s next wave … whatever that may be. Read more below. As you’ve most likely heard, the Supreme Court has halted the COVID-19 vaccine rule for U.S. businesses. (AP News). Canada approves of Pfizer’s COVID-19 pill to be used “for adult patients…